Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03410901
Title TLR9 Agonist SD-101, Anti-OX40 Antibody BMS 986178, and Radiation Therapy in Treating Patients With Low-Grade B-Cell Non-Hodgkin Lymphomas
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Ronald Levy
Indications

B-cell lymphoma

Therapies

BMS-986178 + SD-101

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Stanford University, School of Medicine Palo Alto California 94304 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field